To investigate whether differences in the expression levels of key oncogenes or tumor suppressor genes could explain this disparity, we recently examined the expression of the tumor suppressor gene phosphatase and tensin homolog (PTEN) in a cohort of prostate cancer patients from Jordan, a country of predominantly Arab population in the Eastern Mediterranean region. This evidence concerns the gene PTEN and Familial prostate cancer.